Eagle Pharmaceuticals, Inc. Purchase Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Purchase Agreement among Eagle Pharmaceuticals, Inc., Arsia Therapeutics, LLC, Arsia Therapeutics, Inc., and Others (November 10, 2016)
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2016
Eagle Pharmaceuticals, Inc. Common Stock Purchase Agreement with Underwriters (March 17, 2015)
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2015
Eagle Pharmaceuticals, Inc. Common Stock Purchase Agreement with Underwriters (Piper Jaffray & Co. and William Blair & Company, L.L.C.)
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2014
Security Purchase Option Agreement among Enalare Therapeutics Inc., Securityholders, and Eagle Pharmaceuticals, Inc.
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement between Enalare Therapeutics Inc. and Eagle Pharmaceuticals, Inc. dated August 8, 2022
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement between Tyme Technologies, Inc. and Eagle Pharmaceuticals, Inc. dated January 7, 2020
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2020
Amendment No. 1 to Stock Purchase Agreement by and among Eagle Pharmaceuticals, Inc., Arsia Therapeutics, LLC, Eagle Biologics, Inc., and Amy Schulman
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2018